Skip to content
healthcare.dev

DAPAGLIFLOZIN

NDC 46708-393, DAPAGLIFLOZIN, tablet, film coated, from Alembic Pharmaceuticals Limited.

Product NDC
46708-393
Status
Listed
Labeler
Alembic Pharmaceuticals Limited
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211560
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/46708-393 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DAPAGLIFLOZIN10 mg/1

Pharmacologic classes

Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
46708-393-304670803933030 TABLET, FILM COATED in 1 BOTTLE (46708-393-30)
46708-393-904670803939090 TABLET, FILM COATED in 1 BOTTLE (46708-393-90)
46708-393-91467080393911000 TABLET, FILM COATED in 1 BOTTLE (46708-393-91)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d44f7eed-dd51-40d1-8408-8fb331e1f1f6

Use it

Look up 46708-393 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/46708-393 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 46708-393. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.